Marshall Wace’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.2K Buy
+27,646
New +$78.2K ﹤0.01% 2946
2026
Q1
Sell
-139,148
Closed -$607K 3399
2025
Q4
$607K Buy
139,148
+105,402
+312% +$569K ﹤0.01% 2165
2025
Q3
$142K Buy
33,746
+1,525
+5% +$5.42K ﹤0.01% 2616
2025
Q2
$92.5K Buy
+32,221
New +$85.1K ﹤0.01% 2552
2025
Q1
Sell
-156,058
Closed -$368K 2796
2024
Q4
$368K Buy
156,058
+52,958
+51% +$141K ﹤0.01% 2165
2024
Q3
$244K Buy
103,100
+93,100
+931% +$205K ﹤0.01% 2229
2024
Q2
$19.5K Sell
10,000
-11,643
-54% -$39.6K ﹤0.01% 2471
2024
Q1
$139K Buy
+21,643
New +$197K ﹤0.01% 2273

Other funds holding GNLX

Marshall Wace's GNLX Position: Q2 2026 in Review

Marshall Wace opened a new position in Genelux (GNLX) in Q2 2026: 27,646 shares worth $83.2K. The stake represents ﹤0.01% of the portfolio and ranks #2946 among its holdings. This is a return to the name: Marshall Wace previously reported a position in GNLX as recently as Q4 2025.

Marshall Wace first reported a position in GNLX in Q1 2024 and has held it in 8 quarters since. The position peaked at $607K in Q4 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Marshall Wace held 27,646 shares of Genelux worth $83.2K as of Q2 2026.
  • Genelux was a new Marshall Wace position in Q2 2026.
  • Genelux made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2946 holding.
  • Marshall Wace first reported a position in Genelux in Q1 2024 and has held it in 8 quarters since.
  • Marshall Wace's Genelux position peaked at $607K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.